IJCRR - Vol 06 Issue 11, June, 2014
ENZYMES AND ANTIOXIDANT AS BIOMARKERS IN BREAST CANCER
Author: Pavithra V., Sathisha T. G., K Kasthuri, D. Siva Mallika, S. Jeevan Amos
Objectives: Current study was undertaken to determine the clinical utility of enzyme biomarkers like Alkaline phosphatase and Lactate Dehydrogenase as well as antioxidant like uric acid in diagnosis , prognosis and metastasis. Methods: 50 clinically and histopathologically confirmed female breast cancer patients of the age group of 30-65 years served as cases and 50 normal healthy females in the same age group served as controls. The parameters were estimated by standard biochemical methods. Results: Serum Alkaline Phosphatase and Lactate Dehydrogenase levels are significantly higher in cases than controls. Where as uric acid levels are non significantly increased in cases. Conclusions: Significant increase of serum enzymes Alkaline phosphatase and Lactate Dehydrogenase along with simultaneous non significant increase of uric acid was observed in the study. These biomarkers can be utilized in remote areas where smaller labs operate at low cost and unexposed to sophisticated knowhow.
Keywords: Breast cancer, Alkaline phosphatise, Lactate Dehydrogenase, Uric Acid, Biomarker
Pavithra V., Sathisha T. G., K Kasthuri, D. Siva Mallika, S. Jeevan Amos. ENZYMES AND ANTIOXIDANT AS BIOMARKERS IN BREAST CANCER International Journal of Current Research and Review. Vol 06 Issue 11, June, 24-29
1. Coughlin, S.S., and Ekwueme, D.U. Breast cancer as a global health concern. Cancer Epidemiology 2009; 33:315-318.
2. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
3. Halliwell, B. Oxidative stress and cancer: Have we moved forward? Biochemical Journal 2007; 401: 1-11.
4. Kasapovi?, J., Peji?, S., Stojiljkovi?, V., Todorovi?, A., Radoševi?-Jeli?, L., Sai?i?, Z.S. and et al. Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages after chemotherapy with 5-fluorouracil, doxorubicin and cyclophosphamide. Clinical Biochemistry 2010; 43: 1287-1293.
5. Yeon, J.Y., Suh, Y.J., Kim, S.W., Baik, H.W., Sung, C.J., Kim, H.S. et al. Evaluation of dietary factors in relation to the biomarkers of oxidative stress and inflammation in breast cancer risk. Nutrition 2011; 27: 912-918.
6. Mianying Wang, KapilDhingra, Walter N Hittelman, Joachim G, LiehrMariza de Andrade, Donghui Li. Lipid Peroxidation induced Putative Malondialdehyde - DNA Adducts in Human Breast Tissues’. Cancer Epidemiology, Biomarkers and Prevention 1996; 5:705-10.
7. Singh R, Singh RK, Mahdi AA, Singh RK, Kumar A, Tripathi AK. Circadian periodicity of plasma lipid peroxides and other antioxidants as putative markers in gynecological malignancies. In Vivo 2003; 17:593-600.
8. Cross W.E. et al. Control Mechanisms in Cancer .eds, Raven Press, New York 1976; 411-423.
9. Arathi G, Sachdanandan P. Therapestic effect of Semecarpusanacardium Linn, nut, milk extract on carbohydrate metabolizing and mitochondrial TCA cycle and respiratory chain enzymes in mammary carcinoma rats. Journal of Pharmacy and Pharmacology. Inc 2003; 55 : 1283-1290.
10. Surya Surendren P., Jayanthi G and Smitha K.R. In Vitro Evaluation of the Anticancer Effect of Methanolic Extract of Alstoniascholaris leaves on Mammary Carcinoma. Journal of Applied Pharmaceutical Science 2012; 02 (05):142-149
11. Er O, Frye DK, Kau SW, et al. Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy. Cancer J 2008; 14: 62-68.
12. Aghvami T, Djalali M, Kesharvarz A. Plasma level of antioxidant vitamins and lipid peroxidation in breast cancer patients. Iran J. Publ. Health 2006;35- 42
13. Yeh CC, Hou MF, Tsai SM, Lin SK, Hsiao JK, Huang JC, et al. Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer. ClinChimActa 2005; 381(1-2): 104–111.
14. FarukTas, Hansel H, Belce A, Ilvan S, Argon A, Camlica H, et al. Oxidative stress in breast cancer. Med Oncol 2005; 22 (1): 11-15.
15. Ames, B.N., Cathcart, R., Schwiers, E. and Hochstein, P. Uric acid provides an antioxidant defense in humans against oxidant and radical caused aging and cancer. Proceedings of the National Academy of Sciences.1981. A hypothesis lipid peroxidation/ascorbic acid/pri- mate evolution/erythrocyte aging.1981;78:6858- 6862
16. Cohen, A.M., Aberdrotha, R.E. and Hochstein, P. Inhibition of free radical induced DNA damage by uric acid. FEBS Letters, 1984;174: 147-150
17. Muraoka, S. and Miura, T. Inhibition by uric acid of free radicals that damage biological molecules. Toxicology and Pharmacology 2003; 93: 284-289. 18. Stinefelt, B., Leonard, S.S., Blemings, K.P., Shi, X. and Klandorf, H. Free radical scavenging, DNA protection, and inhibition of lipid per oxidation mediated by uric acid. Annals of Clinical and Laboratory Science 2005; 35: 37-45.
19. O. M. E. Abdel-Salam et al. Open Journal of Molecular and Integrative Physiology 2011; 1: 29-35
20. G. Krishna Veni Et Al. Clinical Evaluation of oxidative stress in women with breast cancer.Recent Research in Science and Technology 2011; 3:55-58.
21. Ming Zhou, Yuhua Zhao, Yan Ding1, Hao Liu, ZixingLiu,Oystein Fodstad, Adam I Riker, et al. Molecular Cancer 2010; 9:33.
22. Mark. E, Stark, MD, CPT, Usaf.MC, Morgan C. D, et.al. Fatal Acute TumorLysis Syndrome with Metastatic Breast Carcinoma. Cancer 1987; 60:762-764.
23. Koukourakis, M., Kontomanolis, E., Giatromanolaki, A.,et al. Serum and tissue LDH levels in patients with breast gynaecological cancer and benign diseases. Gynecologic and Obstetric Investigation. 2009; 67(3):162-168.
24. Jawed Akther, ShabeehNasar and NajninKhanam. Role of LDH as Prognostic Biochemical Marker for Breast Cancer among Poor Patients, a Study at Rural Hospital Md. Indian Journal of Surgery. 10.1007/s12262- 012-0618-1
25. ChandrakanthKh, Nagaraj, JayaprakashMurthy, D, Satishkumar D, and AnandPyati. Study Of Serum Levels Of Gamma- GlutamylTransferase, Lactate Dehydrogenase, Malondialdehyde And Vitamin-E, In Breast Cancer. International Journal of Pharma and Bio Sciences 2011 OctDec; Vol 2, issue 4.
26. Sandhyamishra, D.C.Sharma and Praveen Sharma. Studies of Biochemical parameters in Breast cancer with and without metastasis. Indian Journal of Clinical Biochemistry 2004;19(1): 71-75.
27. Konjevic, G., Jurisic, V., and Spuzic, I. Association of NK cell dysfunction with changes in LDH characteristics of peripheral blood lymphocytes (PBL) in breast cancer patients. Breast Cancer Research and Treatment. 2001; 66(3):255-263.
28. Crivellari, D., Price, K. N., Hagen, M., et al. Routine tests during follow-up of patients after primary treatment for operable breast cancer. International (Ludwig) Breast Cancer Study Group (IBCSG). Annals of Oncology: Official Journal of the EuropeanSociety for Medical Oncology / ESMO. 1995; 6(8):769-776.
29. Hoe AL, Royle GT, Taylor I. Breast liver metastases--incidence, diagnosis and outcome. J R Soc Med 1991; 84: 714-716
30. Singletary SE, Walsh G, Vauthey JN, et al. A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist 2003; 8: 241-251.
31. Clevert DA, Jung EM, Stock KF, Weckbach S, Feuerbach S, Reiser M, et al. Evaluation of malignant liver tumors: biphasic MSCT versus quantitative contrast harmonic imaging ultrasound. Z Gastroenterol 2009; 47: 1195- 1202
32. .Berman CG, Clark RA. Diagnostic imaging in cancer. Prim Care 1992; 19: 677-713.
33. Wyld L, Gutteridge E, Pinder SE, et al. Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer 2003; 89: 284-290.
34. Ramaswamy, G., Rao, V.R., Krishnamoorthy, L., Ramesh, G., Gomathy, R. and Renukadevi, D. Serum levels of bone alkaline phosphatase in breast and prostate cancer with bone metastasis. Indian J. Clin. Biochem.2000; 15 (2): 110-113.
35. Lamerz, R., Stieber, P. and Fateh - Moghadam, A. Serum marker combinations in human breast cancer (review). In Vivo 1993; 7 : 607-13
36. Cao et al. Serological Diagnosis of Liver Metastasis from Breast Cancer. Cancer Bio Med 2012; 57-62